tiprankstipranks
Trending News
More News >
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market

Compass Therapeutics (CMPX) Income Statement

Compare
418 Followers

Compass Therapeutics Income Statement

Last quarter (Q3 2025), Compass Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Compass Therapeutics's net income was $-14.26M. See Compass Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 850.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 850.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 57.48M$ 50.36M$ 41.66M$ 81.88M$ 27.81M
Depreciation and Amortization
$ 1.75M$ 1.89M$ 1.90M$ 1.62M$ 2.40M
EBITDA
$ -54.87M$ -48.47M$ -39.75M$ -80.19M$ -25.41M
Operating Income
$ -56.63M$ -50.36M$ -41.66M$ -81.88M$ -27.81M
Other Income/Expenses
$ 7.25M$ 7.87M$ 2.43M$ -299.00K$ -1.66M
Pretax Income
$ -49.38M$ -42.49M$ -39.23M$ -82.18M$ -29.47M
Net Income
$ -49.38M$ -42.49M$ -39.23M$ -82.18M$ -29.50M
Per Share Metrics
Basic EPS
$ -0.36$ -0.33$ -0.35$ -1.31$ -0.52
Diluted EPS
$ -0.36$ -0.33$ -0.35$ -1.31$ -0.52
Weighted Average Shares Outstanding
137.11M 127.03M 105.19M 62.87M 56.22M
Weighted Average Shares Outstanding (Diluted)
137.11M 127.03M 105.19M 62.87M 56.22M
Currency in USD

Compass Therapeutics Earnings and Revenue History